REPORT
EXCLUSIVE LIFE SCIENCE FEATURE
The latest industry trends and proprietary data from Nice Insight survey results
36
LIFESCIENCELEADER.COM JULY 2014 CMO SUPPLEMENT
Emerging/Niche & Start-up Buyers Who Would
Consider CMOs in Emerging Makets
The Percentage Who Are Already Working With
CMOs in Emerging Markets
The Percentage Who Believe the Quality
Level Is Too Risky
■ Emerging Pharma ■ Emerging Biotech
■ Emerging Pharma ■ Emerging Biotech
■ Emerging Pharma ■ Emerging Biotech
■ Emerging Pharma ■ Emerging Biotech
■ Emerging Pharma ■ Emerging Biotech
55%
46%
33%
78%
56%
92%
45%
66%
27%
3%
Large Molecule API / Biologics
Injectables Product Development
Solid Dosage Forms
Solid Dose, Semi Solids,
& Liquid Development
Semi-Solids & Liquids
Other Delivery Forms
(Inhalable / Transdermal)
Specialty Dosage Forms
Injectables
Small Molecule API
32%
48%
49%
70%
26%
30%
37%
70%
27%
64%
50%
56%
Development Services by Buyer Group
Manufacturing Services by Buyer Group
Small Molecule API & Advanced
Intermediates
Large Molecule API / Biologics
Development &
Phase I/II Clinical Trial
Material Services
Commercial Scale
Manufacturing
Services
Emerging Pharma Emerging Biotech
Emerging Pharma Emerging Biotech
67%
24%
14%
86%
60%
6%
0 7 1 4 _ R e s e a r c h _ R e p o r t s _ O I _ S p o n s o r . i n d d 3 0714_Research_Reports_OI_Sponsor.indd 3 6 / 2 3 / 2 0 1 4 2 : 3 5 : 3 8 P M 6/23/2014 2:35:38 PM